Source: hiv.gov

Director’s Note from Richard Wolitski, Ph.D., Director, HHS Office of HIV/AIDS and Infectious Disease Policy: This news from FDA last week is important since it provides an additional treatment option for many people living with HIV. 

Click Here To Read More